Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance
CA: A Cancer Journal for Clinicians · 2024
DOI: 10.3322/caac.21825 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, 2024. Verfasst von Raffaella Casolino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Wohl Cancer Research Center, School of Cancer Sciences, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Genomics, Genetic Testing. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The last decade has seen rapid progress in the use of genomic tests, including gene panels, whole‐exome sequencing, and whole‐genome sequencing, in research and clinical cancer care. These advances have created expansive opportunities to characterize the molecular attributes of cancer, revealing a subset of cancer‐associated aberrations called driver mutations . The identification of these driver mutations can unearth vulnerabilities of cancer cells to targeted therapeutics, which has led to the development and approval of novel diagnostics and personalized interventions in various malignancies. The applications of this modern approach, often referred to as precision oncology or precision cancer medicine , are already becoming a staple in cancer care and will expand exponentially over the coming years. Although genomic tests can lead to better outcomes by informing cancer risk, prognosis, and therapeutic selection, they remain underutilized in routine cancer care. A contributing factor is a lack of understanding of their clinical utility and the difficulty of results interpretation by the broad oncology community. Practical guidelines on how to interpret and integrate genomic information in the clinical setting, addressed to clinicians without expertise in cancer genomics, are currently limited. Building upon the genomic foundations of cancer and the concept of precision oncology, the authors have developed practical guidance to aid the interpretation of genomic test results that help inform clinical decision making for patients with cancer. They also discuss the challenges that prevent the wider implementation of precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wolfson Wohl Cancer Research Center, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
- Hull York Medical School, York, UK.
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Surgery, Weill Cornell Medicine, New York City, New York, USA.
- Department of Public Health, University of Naples Federico II, Naples, Italy.
- Laboratory of Translational Oncology and Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors IEO European Institute of Oncology, IRCCS, Milan, Italy.
ORCID-Profile: Raffaella Casolino
Förderung
- NCI NIH HHS
Zitieren
APA
Casolino, R., Beer, P. A., Chakravarty, D., Davis, M. B., Malapelle, U., Mazzarella, L., Normanno, N., Pauli, C., Subbiah, V., Turnbull, C., Westphalen, C. B., & Biankin, A. V. (2024). Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.21825
Vancouver
Casolino R, Beer PA, Chakravarty D, Davis MB, Malapelle U, Mazzarella L, et al. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance. CA: A Cancer Journal for Clinicians. 2024. doi:10.3322/caac.21825
BibTeX
@article{Casolino2024,
author = {Casolino, Raffaella and Beer, Philip A and Chakravarty, Debyani and Davis, Melissa B and Malapelle, Umberto and Mazzarella, Luca and Normanno, Nicola and Pauli, Chantal and Subbiah, Vivek and Turnbull, Clare and Westphalen, C Benedikt and Biankin, Andrew V},
title = {Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance},
journal = {CA: A Cancer Journal for Clinicians},
year = {2024},
doi = {10.3322/caac.21825}
}
EUVIMED